ACT logo

AlzChem Group Stock Price

Symbol: XTRA:ACTMarket Cap: €1.6bCategory: Materials

ACT Share Price Performance

€154.40
103.60 (203.94%)
6.5% overvalued intrinsic discount
€145.00
Fair Value
€154.40
103.60 (203.94%)
6.5% overvalued intrinsic discount
€145.00
Fair Value
Price €154.40
AnalystHighTarget €145.00
AnalystConsensusTarget €124.40
AnalystLowTarget €97.00

ACT Community Narratives

AN
AnalystHighTarget
AnalystHighTarget·Updated
Fair Value €145.00 6.5% overvalued intrinsic discount

Environmental Risks And Food Security Will Open Specialty Markets

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget·Updated narrative
Fair Value €135.24 14.2% overvalued intrinsic discount

Global Nutrition Trends And Capacity Expansions Will Unlock Opportunities

2users have liked this narrative
0users have commented on this narrative
17users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget·Updated
Fair Value €97.00 59.2% overvalued intrinsic discount

Mounting Regulatory And Raw Material Headwinds Will Undermine Specialty Chemicals

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

ACT Community Fair Values

Recent ACT News & Updates

No updates

AlzChem Group AG Key Details

€566.3m

Revenue

€207.7m

Cost of Revenue

€358.5m

Gross Profit

€300.6m

Other Expenses

€57.9m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
5.71
Gross Margin
63.32%
Net Profit Margin
10.23%
Debt/Equity Ratio
20.2%

AlzChem Group AG Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About ACT

Founded
1908
Employees
1647
CEO
Andreas Niedermaier
WebsiteView website
www.alzchem.com

AlzChem Group AG, together with its subsidiaries, develops, produces, and markets a range of chemical specialties in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The Specialty Chemicals segment sells specialty chemical products that are used in the chemical, food, animal feed, defence technology, and renewable energies industries. This segment manufactures composite materials and adhesives, as well as silicon nitride for ceramics; and photovoltaic modules in the solar industry. The Basics & Intermediates segment produces raw materials for specialty chemicals; and products for agriculture and metallurgy, as well as intermediates for the chemical industry that are produced from lime, carbon, and electricity. This segment also engages in the production and sale of guanidine salts as a raw material for agrochemicals and active pharmaceutical ingredients. The Other & Holding segment provides chemical park operations and administrative services, as well as produces and distributes various infrastructure services. It offers products and services to agricultural sector under the CALCIUM CYANAMIDE PERLKA, EMINEX, DORMEX, ALZOGUR, SITOFEX, and BREAK-THRU brands; animal nutrition sector under the CREAMINO brands; human nutrition sector under the CREAPURE, CREAVITALIS, LIVADUR, and ALIPURE brands; pharma sector under the GUANIDINE SALTS – BIOSELECT brand; fine chemicals sector under the GUANIDINSALZE -BIOSELECT, CYANAMIDE, DICYANDIAMIDE, GUANAMINE, NITRILES, MELFLOCK and ALZOFIX, THIOUREA, and NITROGUANIDINE brands; metallurgy sector under the CAD, CALCIPRO, and CALZOT brands, as well as technical gases and calcium carbide; renewable energy sector under the DYHARD and SILZOT brands; and custom synthesis, such as toll micronization and manufacturing. The company was founded in 1908 and is based in Trostberg, Germany.

German Market Performance

  • 7 Days: 1.2%
  • 3 Months: -2.8%
  • 1 Year: 23.7%
  • Year to Date: 6.0%
The market is up 1.2% over the last week, with the Communication Services sector leading the way, up 13%. In contrast, the Consumer Discretionary sector is lagging, dropping 4.7%. The market is up 24% over the last 12 months. Looking forward, earnings are forecast to grow by 17% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading